| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 19 |
| 1 | METHOTREXATE | 16 |
| 2 | CAPECITABINE | 11 |
| 3 | TACROLIMUS | 11 |
| 4 | PREDNISONE | 10 |
| 5 | ALLOPURINOL | 9 |
| 6 | IBUPFROFEN | 9 |
| 7 | IBUPROFEN | 9 |
| 8 | IBUPROFEN 200 MG | 9 |
| 9 | IBUPROFEN 200MG | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM TETRADECYL SULFATE | 1 | 0.0182 |
| 1 | ONTRUZANT | 2 | 0.0038 |
| 2 | NITAZOXANIDE | 1 | 0.0029 |
| 3 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 1 | 0.0023 |
| 4 | SEVELAMER HYDROCHLORIDE | 1 | 0.0017 |
| 5 | IBRITUMOMAB TIUXETAN | 1 | 0.0007 |
| 6 | RAMUCIRUMAB | 3 | 0.0005 |
| 7 | MICAFUNGIN SODIUM | 3 | 0.0005 |
| 8 | CLOFARABINE | 1 | 0.0004 |
| 9 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 19 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 17 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 17 |
| 3 | Platinum-based Drug [EPC] | 16 |
| 4 | Azole Antifungal [EPC] | 15 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 9 |
| 7 | RANK Ligand Inhibitor [EPC] | 8 |
| 8 | Benzodiazepine [EPC] | 6 |
| 9 | Alkylating Drug [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 1 | Echinocandin Antifungal [EPC] | 3 | 0.0004 |
| 2 | Cannabinoid [EPC] | 2 | 0.0002 |
| 3 | Sigma-1 Agonist [EPC] | 1 | 0.0001 |
| 4 | Glinide [EPC] | 1 | 0.0001 |
| 5 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 6 | Azole Antifungal [EPC] | 15 | 0.0001 |
| 7 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 8 | Penem Antibacterial [EPC] | 3 | 0.0001 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 3 | 0.0001 |